Our Lady of Lourdes Memorial Hospital INC.

Our Lady of Lourdes Memorial Hospital INC. was paid $58.52M by Medicaid between Jan 2018 and Dec 2024, across 440 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 15% of everything it billed.

33Billing provider infoOUR LADY OF LOURDES MEMORIAL HOSPITAL INC.
BINGHAMTON, NY 13905

33aNPI1629087580assigned 08/07/2006

33bProvider typeGeneral Acute Care Hospital

28Total paid$58.52M

24GClaims1,298,786

24DCodes billed440

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other General Acute Care Hospital providers in New York

Rank by total paid#27 of 231

Median peer was paid$561K

This provider vs. median104×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	4,037	$141K
2019	74,730	$3.11M
2020	214,116	$8.53M
2021	276,964	$12.73M
2022	281,913	$13.27M
2023	277,495	$12.73M
2024incomplete	169,531	$8.00M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	15%	86,214	77,637	$8.57M
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	12%	64,857	58,692	$6.75M
90834	Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient	5.5%	24,359	14,659	$3.22M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	5.0%	22,708	21,325	$2.94M
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	4.3%	32,524	31,115	$2.49M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	3.8%	15,840	15,347	$2.23M
96361	Intravenous infusion, hydration; each additional hour	2.6%	6,976	6,291	$1.52M
80053	Comprehensive metabolic panel	2.0%	63,030	57,534	$1.20M
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	2.0%	9,638	9,179	$1.15M
70450	Computed tomography, head or brain; without contrast material	1.9%	3,974	3,906	$1.13M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.9%	4,523	4,430	$1.12M
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.7%	16,278	5,691	$1.02M

428 more codes

36415	Collection of venous blood by venipuncture	1.6%	103,020	$940K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	1.5%	2,752	$853K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.4%	3,009	$831K
45380	Colonoscopy, flexible; with biopsy, single or multiple	1.4%	1,173	$796K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	1.2%	1,189	$712K
90832	Psychotherapy session, about 30 minutes	1.2%	7,124	$711K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	1.2%	5,124	$680K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	1.1%	3,856	$653K
99204	Doctor's office visit, new patient (more involved)	<1%	5,205	$578K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	16,854	$547K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	10,932	$479K
99203	Doctor's office visit, new patient (routine)	<1%	4,374	$470K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	7,572	$466K
T1030	Nursing care, in the home, by registered nurse, per diem	<1%	2,862	$462K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	11,423	$452K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	1,956	$416K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	8,203	$404K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,743	$395K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	1,460	$390K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	1,292	$358K
71275	Computed tomographic angiography, chest, with contrast material	<1%	1,124	$340K
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	2,327	$324K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	7,656	$322K
99215	Doctor's office visit, returning patient (complex)	<1%	2,830	$303K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	5,473	$301K
97161		<1%	3,364	$286K
S9131	Physical therapy; in the home, per diem	<1%	4,161	$279K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	<1%	3,361	$278K
76770		<1%	1,442	$277K
84443	Thyroid stimulating hormone (TSH)	<1%	29,398	$275K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	1,446	$263K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	<1%	2,968	$256K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	10,571	$255K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	3,215	$247K
20610		<1%	985	$222K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	<1%	2,494	$202K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	422	$199K
80061	Lipid panel	<1%	22,761	$186K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	<1%	2,147	$176K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	6,870	$175K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	50,186	$165K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	4,004	$164K
12001		<1%	417	$163K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	517	$156K
90791	Psychiatric diagnostic evaluation	<1%	964	$154K
83880		<1%	4,732	$148K
84439		<1%	14,983	$146K
73221		<1%	535	$144K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	<1%	1,797	$143K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	6,953	$141K
76801		<1%	1,773	$136K
93970		<1%	357	$135K
80048	Basic metabolic panel (calcium, ionized)	<1%	8,764	$126K
83036	Hemoglobin; glycosylated (A1C)	<1%	15,925	$125K
S9128	Speech therapy, in the home, per diem	<1%	1,199	$123K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	1,638	$121K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	2,406	$115K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	164	$113K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	801	$111K
93971		<1%	1,392	$108K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	361	$107K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	2,411	$105K
72141		<1%	372	$105K
86850		<1%	4,117	$104K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	8,122	$104K
42820	Tonsillectomy and adenoidectomy; younger than age 12	<1%	77	$103K
87070		<1%	16,952	$102K
71250		<1%	968	$100K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	3,527	$99K
94726		<1%	1,788	$97K
99205	Prolong outpt/office vis	<1%	850	$97K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	662	$96K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	755	$93K
88342		<1%	1,494	$92K
97535	Self-care/home management training, each 15 minutes	<1%	2,701	$92K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	4,021	$81K
93010	Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only	<1%	11,542	$80K
87086	Culture, bacterial; quantitative colony count, urine	<1%	14,763	$79K
76641		<1%	3,159	$77K
86901		<1%	4,468	$74K
82607		<1%	5,810	$73K
90686		<1%	3,529	$71K
86900		<1%	4,470	$62K
71046	Radiologic examination, chest; 2 views	<1%	8,322	$61K
S9129	Occupational therapy, in the home, per diem	<1%	981	$61K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	4,310	$61K
76830	Ultrasound, transvaginal	<1%	1,506	$59K
90715		<1%	2,171	$55K
94060		<1%	622	$55K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	136	$54K
G0378	Hospital observation service, per hour	<1%	1,758	$54K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	93	$52K
84153		<1%	3,222	$51K
77063	Screening digital breast tomosynthesis, bilateral	<1%	4,646	$51K
87634		<1%	2,466	$46K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	12,538	$45K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,593	$45K
82728		<1%	3,680	$43K
85610		<1%	12,744	$42K
71271		<1%	720	$42K
70491		<1%	163	$40K
76942		<1%	241	$40K
76536		<1%	1,661	$39K
99406		<1%	1,141	$38K
90651		<1%	836	$37K
84702		<1%	3,664	$37K
86480		<1%	582	$36K
77080		<1%	720	$35K
87077		<1%	5,166	$35K
41899	Unlisted procedure, dentoalveolar structures	<1%	30	$35K
94010		<1%	827	$35K
94729		<1%	1,762	$33K
83655		<1%	2,364	$32K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	1,557	$31K
87081		<1%	7,744	$31K
90647		<1%	1,749	$30K
90837	Psychotherapy session, about an hour	<1%	217	$30K
93017		<1%	265	$29K
93975		<1%	104	$29K
86780		<1%	2,839	$29K
12011		<1%	76	$29K
82746		<1%	2,831	$29K
90723		<1%	1,667	$29K
84403		<1%	1,196	$28K
86803		<1%	3,504	$28K
84144		<1%	1,408	$28K
76819	Fetal biophysical profile; without non-stress testing	<1%	761	$27K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	1,070	$26K
82043		<1%	5,015	$26K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	1,379	$26K
90680		<1%	1,437	$25K
73630		<1%	4,488	$25K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	114	$25K
86140		<1%	11,402	$24K
90688		<1%	1,203	$24K
94618		<1%	869	$24K
G0447	Face-to-face behavioral counseling for obesity, 15 minutes	<1%	266	$24K
81001		<1%	11,348	$23K
86618		<1%	1,967	$23K
90670		<1%	1,220	$23K
87340		<1%	2,505	$23K
80076		<1%	1,956	$22K
86762		<1%	1,752	$22K
90633		<1%	1,319	$22K
73610		<1%	3,885	$21K
97035		<1%	1,128	$21K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	379	$21K
87653		<1%	955	$20K
82670		<1%	738	$19K
90734		<1%	1,036	$19K
73130		<1%	3,272	$19K
88304		<1%	506	$19K
86003		<1%	399	$18K
84466		<1%	1,822	$18K
83001		<1%	1,010	$18K
99385		<1%	214	$18K
85027		<1%	6,951	$18K
84146		<1%	922	$17K
73030		<1%	2,791	$17K
87186		<1%	3,966	$17K
88112		<1%	335	$17K
90677		<1%	380	$17K
73562		<1%	2,643	$17K
83540		<1%	3,654	$17K
81025		<1%	5,256	$16K
87522	Neg quan hep c or qual rna	<1%	340	$16K
83970		<1%	395	$16K
72125	Computed tomography, cervical spine; without contrast material	<1%	278	$16K
12002		<1%	40	$16K
70486		<1%	153	$16K
87205		<1%	6,282	$15K
Q3014	Telehealth originating site facility fee	<1%	894	$15K
29515		<1%	76	$15K
77065	Tomosynthesis, mammo	<1%	205	$15K
82805		<1%	572	$15K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	6,104	$15K
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	8,717	$15K
73564		<1%	1,745	$14K
85730		<1%	6,785	$14K
93880		<1%	52	$14K
72110		<1%	1,079	$14K
11721		<1%	256	$14K
77002		<1%	91	$14K
93225		<1%	175	$14K
97165		<1%	200	$13K
77066	Tomosynthesis, mammo	<1%	218	$13K
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	131	$13K
29125		<1%	66	$13K
83002		<1%	791	$13K
62323		<1%	27	$13K
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	3,501	$13K
76870		<1%	311	$13K
72100		<1%	2,000	$12K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	633	$12K
85007		<1%	5,741	$12K
73110		<1%	2,046	$11K
83735		<1%	5,734	$11K
86376		<1%	870	$11K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	224	$11K
97014		<1%	522	$10K
85652		<1%	4,531	$10K
90707		<1%	506	$10K
82565		<1%	2,208	$10K
82784		<1%	986	$10K
81003		<1%	7,872	$10K
92550		<1%	336	$9K
10060		<1%	36	$9K
76775		<1%	156	$9K
90700		<1%	536	$9K
86038		<1%	1,959	$9K
86706		<1%	1,150	$9K
90696		<1%	415	$9K
90716		<1%	481	$8K
73700		<1%	65	$8K
82570		<1%	1,914	$8K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	12	$8K
51798		<1%	27	$8K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	188	$8K
86765		<1%	787	$8K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	4,473	$8K
90710		<1%	452	$8K
84481		<1%	911	$8K
80305		<1%	3,867	$8K
86431		<1%	1,535	$7K
J3490	Unclassified drugs	<1%	118	$7K
76642		<1%	417	$7K
86800		<1%	663	$7K
73502		<1%	1,350	$7K
86769		<1%	235	$7K
97162		<1%	60	$7K
73140		<1%	1,945	$7K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	4,383	$7K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	1,119	$7K
93922		<1%	89	$7K
86704		<1%	790	$6K
99493		<1%	165	$6K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	8,831	$6K
97802		<1%	315	$6K
74183		<1%	24	$6K
97803		<1%	308	$6K
72040		<1%	926	$6K
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	<1%	501	$6K
99442		<1%	68	$5K
99383		<1%	59	$5K
84436		<1%	818	$5K
83021		<1%	249	$5K
71045	Radiologic examination, chest; single view	<1%	4,916	$5K
82950		<1%	959	$5K
83690		<1%	5,547	$5K
93242		<1%	40	$5K
99443		<1%	52	$4K
73100		<1%	843	$4K
82105		<1%	550	$4K
85014		<1%	1,005	$4K
99386		<1%	52	$4K
84550		<1%	996	$4K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	43	$4K
D2930	Prefabricated stainless steel crown - primary tooth	<1%	14	$4K
86787		<1%	575	$4K
99401		<1%	158	$3K
72170		<1%	663	$3K
84484		<1%	6,075	$3K
73560		<1%	686	$3K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	<1%	34	$3K
85045		<1%	1,008	$3K
86665		<1%	122	$3K
72131		<1%	13	$3K
87040		<1%	2,635	$3K
74018		<1%	1,027	$3K
74019		<1%	488	$3K
17110		<1%	12	$3K
83550		<1%	653	$3K
87902		<1%	13	$3K
82785		<1%	263	$3K
85379		<1%	1,344	$3K
77427		<1%	25	$3K
87469		<1%	125	$3K
82533		<1%	176	$3K
92557		<1%	104	$3K
73080		<1%	561	$3K
72050		<1%	269	$2K
99051		<1%	206	$2K
86757		<1%	128	$2K
85018		<1%	1,062	$2K
82150		<1%	1,598	$2K
97116		<1%	57	$2K
86364		<1%	386	$2K
86308		<1%	690	$2K
83605		<1%	4,043	$2K
84480		<1%	371	$2K
90750		<1%	14	$2K
82550		<1%	1,271	$2K
86141		<1%	227	$2K
86708		<1%	292	$2K
86258		<1%	195	$2K
84703		<1%	4,456	$2K
90656		<1%	195	$2K
92567		<1%	82	$2K
73590		<1%	444	$2K
80069		<1%	91	$2K
87468		<1%	58	$2K
73090		<1%	462	$2K
90620		<1%	62	$2K
84100		<1%	460	$2K
81002		<1%	3,789	$2K
82962		<1%	5,067	$2K
0011A		<1%	40	$2K
0012A		<1%	38	$1K
99441		<1%	22	$1K
G0109	Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes	<1%	79	$1K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	818	$1K
86664		<1%	122	$1K
69210		<1%	50	$1K
86235		<1%	108	$1K
C9399	Unclassified drugs or biologicals	<1%	25	$1K
82248		<1%	317	$1K
74210		<1%	124	$1K
96367		<1%	26	$1K
96375	Therapeutic injection; each additional sequential IV push	<1%	3,017	$1K
86663		<1%	122	$1K
87430		<1%	1,175	$1K
87484		<1%	58	$1K
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	1,578	$1K
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	146	$1K
83516		<1%	43	$1K
71101		<1%	129	$1K
84520		<1%	306	$1K
86709		<1%	150	$1K
0071A		<1%	27	$1K
86735		<1%	160	$1K
82947		<1%	242	$1K
90472	Immunization administration, each additional vaccine (list separately)	<1%	217	$994.20
H0049	Alcohol and/or drug screening	<1%	21	$933.33
87507		<1%	13	$918.50
82627		<1%	49	$890.27
80349		<1%	511	$882.33
87252		<1%	26	$866.12
80047		<1%	80	$862.34
83020		<1%	69	$834.23
86225		<1%	161	$789.18
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	13	$722.44
73070		<1%	190	$708.91
P9612	Catheterization for collection of specimen, single patient, all places of service	<1%	39	$679.25
92587		<1%	24	$672.66
A9575	Injection, gadoterate meglumine, 0.1 ml	<1%	82	$671.77
0031A		<1%	17	$620.96
G0008	Administration of influenza virus vaccine	<1%	86	$606.57
J0690	Injection, cefazolin sodium, 500 mg	<1%	1,250	$589.21
90732		<1%	14	$569.89
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	<1%	845	$497.14
88313		<1%	53	$489.10
84425		<1%	39	$469.34
96127		<1%	335	$433.41
86617		<1%	28	$420.42
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	63	$416.78
83615		<1%	122	$384.36
72114		<1%	25	$381.27
86200		<1%	50	$369.76
80178		<1%	50	$360.17
94760		<1%	978	$357.27
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	13	$347.10
96376		<1%	336	$313.08
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	4,668	$249.66
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	3,672	$246.74
82378		<1%	15	$237.02
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	447	$227.46
72072		<1%	13	$220.89
86580		<1%	42	$213.71
87210		<1%	95	$195.80
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,414	$184.38
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	3,140	$183.52
87045		<1%	27	$180.41
99495		<1%	412	$175.72
73620		<1%	56	$158.13
87147		<1%	108	$155.97
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	3,509	$154.93
93000		<1%	12	$154.00
82985		<1%	15	$153.25
81015		<1%	53	$139.10
J7050	Infusion, normal saline solution, 250 cc	<1%	349	$126.84
73660		<1%	30	$103.80
J7030	Infusion, normal saline solution , 1000 cc	<1%	104	$80.95
J1040	Injection, methylprednisolone acetate, 80 mg	<1%	81	$78.16
J1030	Injection, methylprednisolone acetate, 40 mg	<1%	119	$76.32
J3370	Injection, vancomycin hcl, 500 mg	<1%	53	$75.16
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,007	$74.44
82977		<1%	13	$64.00
84132		<1%	13	$59.73
72070		<1%	12	$46.80
83721		<1%	17	$43.04
82077		<1%	172	$35.92
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	920	$35.73
87207		<1%	12	$31.15
J1170	Injection, hydromorphone, up to 4 mg	<1%	125	$30.84
80320		<1%	153	$26.51
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	773	$20.13
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	25	$18.47
J0330	Injection, succinylcholine chloride, up to 20 mg	<1%	139	$15.40
99490	Ccm add 20min	<1%	25	$14.11
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	<1%	28	$13.58
T2022	Case management, per month	<1%	25	$13.00
J2704	Injection, propofol, 10 mg	<1%	38	$6.07
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	65	$3.28
99173		<1%	48	$3.09
87220		<1%	14	$2.90
J1644	Injection, heparin sodium, per 1000 units	<1%	83	$2.07
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	215	$2.06
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	409	$1.30
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	53	$0.63
Q0162	Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen	<1%	15	$0.02
Q0243	Injection, casirivimab and imdevimab, 2400 mg	<1%	28	$0.02
91301		0%	107	$0.00
J2060	Injection, lorazepam, 2 mg	0%	29	$0.00
91303		0%	17	$0.00
95806		0%	24	$0.00
99153	Mod sedat endo service >5yrs	0%	16	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	14	$0.00
99496		0%	26	$0.00
99024		0%	14	$0.00
99492		0%	12	$0.00
88300		0%	14	$0.00
87400		0%	146	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	55	$0.00
99152		0%	98	$0.00
J1650	Injection, enoxaparin sodium, 10 mg	0%	83	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	40	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	15	$0.00
90461		0%	32	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialSANNE, LYNN (AVP REVENUE SERVICES)